Atherosclerosis as a possible extrahepatic manifestation of chronic hepatitis C virus infection.
Chronic infection and associated inflammation may play a role in various unfavorable pathologic conditions, including atherosclerosis. Chronic hepatitis C virus (HCV) infection is thought to be associated with a higher prevalence of atherosclerotic vascular changes in the coronary artery, cerebrovascular artery, and carotid artery; however, little is known about the precise mechanisms by which HCV enhances atherogenic processes. Furthermore, some studies have found no association, or even an inverse association, between HCV infection and atherosclerotic vascular changes or cardiovascular events. Differences in data regarding the mode of association may be because of variations in sample size, target population, and study design. Nevertheless, physicians should be aware of cardiovascular disorders as a possible comorbidity - owing to their considerable consequences - among patients with chronic HCV infection.
['Ishizaka|Nobukazu|N|', 'Ishizaka|Yuko|Y|', 'Yamkado|Minoru|M|']
atherosclerosis hepatitis C virus coronary artery disease